Loading…
Made in America Emergency Preparedness Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
63pct
4d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Made in America Emergency Preparedness Act This bill establishes in the legislative branch the National Commission on United States Preparedness for National Emergencies and requires any medical, pharmaceutical, or emergency preparedness product deemed integral to a response to a national emergency to be manufactured and procured in the United States beginning on and after January 1, 2026. The commission must, among other things, examine and report on the COVID-19 pandemic in the United States in 2020 and the private sector response, investigate the origin of the COVID-19 virus and measures for mitigating the impacts of future physical and medical national disasters, determine what medical, pharmaceutical, and emergency preparedness products are deemed to be essential to emergency preparedness, and report on infrastructure or capability deficiencies in hospitals and medical centers. States must implement the commission's findings or lose access to federal emergency preparedness funds. The bill allows 100% tax expensing for qualified pharmaceutical and medical device manufacturing property (e.g., personal protective equipment) placed in service after 2020 and before 2027.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2022 · fourth_quarter · Medical/Disease Research/Clinical Labs
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services), H.R.8188, To amend title XVIII of the Social Security Act to improve the accuracy of market-based Medicare payment for clinical diagnostic laboratory services, to reduce administrative burdens in the collection of data, and for other purposes; Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Coronavirus impact and response; Implementation of H.R.3584/S.3049, Laboratory Access for Beneficiaries Act (P.L.116-94); H.R.8188/S.4449, Saving Access to Laboratory Services Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; S.2209/H.R.4128, Verifying Accurate Leading-edge IVCT Development Act 6 of 2021; H.R.6000, Cures 2.0 Act; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); S.3799, PREVENT Pandemics Act; H.R.8152, American Data Privacy and Protection Act; H.R.6202, Telehealth Extension Act of 2021; H.R.2617, Consolidated Appropriations Act, 2023.
Referred to the Subcommittee on Economic Development, Public Buildings, and Emergency Management.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Oversight, Management, and Accountability.
Referred to the Committee on Transportation and Infrastructure, and in addition to the Committees on Ways and Means, Oversight and Reform, Homeland Security, Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · third_quarter · Medical/Disease Research/Clinical Labs
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services), H.R.8188, To amend title XVIII of the Social Security Act to improve the accuracy of market-based Medicare payment for clinical diagnostic laboratory services, to reduce administrative burdens in the collection of data, and for other purposes, S.4449, Saving Access to Laboratory Services Act; Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Coronavirus impact and response; Implementation of H.R.3584/S.3049, Laboratory Access for Beneficiaries Act (P.L.116-94); H.R.7667, Food and Drug Amendments of 2022, S.4348, FDASLA Act of 2022, H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180); S.2209/H.R.4128, Verifying Accurate Leading-edge IVCT Development Act 6 of 2021; H.R.6000, Cures 2.0 Act; FY2022 Budget Reconciliation/Inflation Reduction Act of 2022 (H.R.5376, P.L.117-169); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); S.3799, PREVENT Pandemics Act; H.R.8152, American Data Privacy and Protection Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Medical/Disease Research/Clinical Labs
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services), H.R.8188, To amend title XVIII of the Social Security Act to improve the accuracy of market-based Medicare payment for clinical diagnostic laboratory services, to reduce administrative burdens in the collection of data, and for other purposes, S.4449, Saving Access to Laboratory Services Act; Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Coronavirus impact and response; Implementation of H.R.3584/S.3049, Laboratory Access for Beneficiaries Act (P.L.116-94); MDUFA Reauthorization, H.R.7667, Food and Drug Amendments of 2022, S.4348, FDASLA Act of 2022; S.2209/H.R.4128, Verifying Accurate Leading-edge IVCT Development Act 6 of 2021; H.R.6000, Cures 2.0 Act; FY2022 Budget Reconciliation (H.R.5376); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, Senate); S.3799, PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · first_quarter · Medical/Disease Research/Clinical Labs
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services); Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Coronavirus impact and response; Implementation of H.R.3584/S.3049, Laboratory Access for Beneficiaries Act (P.L.116-94); Implementation of H.R.748, CARES Act (P.L.116-136); MDUFA Reauthorization; S.2209/H.R.4128, Verifying Accurate Leading-edge IVCT Development Act 6 of 2021; H.R.6000, Cures 2.0 Act; FY2022 Budget Reconciliation (H.R.5376); FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103); Y2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; S.3799, PREVENT Pandemics Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · fourth_quarter · Transportation
HR 3584, Infrastructure Investment and Jobs Act, provisions relating to in infrastructure.
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medical/Disease Research/Clinical Labs
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services); Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Coronavirus impact and response; Implementation of H.R.3584/S.3049, Laboratory Access for Beneficiaries Act (P.L.116-94); Implementation of H.R.748, CARES Act (P.L.116-136); S.2209/H.R.4128, Verifying Accurate Leading-edge IVCT Development Act 6 of 2021; H.R.6000, Cures 2.0 Act; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502/S.3062); FY2022 Budget Resolution (S.Con.Res.14) and Budget Reconciliation (H.R.5376); S.610, Protecting Medicare and American Farmers from Sequester Cuts Act (P.L.117-71).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · third_quarter · Medical/Disease Research/Clinical Labs
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services); Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Coronavirus impact and response; Implementation of H.R.3584/S.3049, Laboratory Access for Beneficiaries Act (P.L.116-94); Implementation of H.R.748, CARES Act (P.L.116-136); S.2209/H.R.4128, Verifying Accurate Leading-edge IVCT Development Act 6 of 2021; CURES 2.0 Act discussion draft; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); FY2022 Budget Resolution (S.Con.Res.14) and Budget Reconciliation (H.R.5376).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · third_quarter · Defense
H.R. 1319 - American Rescue Plan Act of 2021 H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022 H.R. 3584 - Invest in America Act Senate Department of Appropriations Act, 2021 Secretary of the Air Force (Frank Kendall) concerning defense programs.
Client expense: $230,000 · Firm income: Not reported
Government targets: Air Force, Dept of, Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Medical/Disease Research/Clinical Labs
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services); Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Coronavirus impact and response; Implementation of H.R.3584/S.3049, Laboratory Access for Beneficiaries Act (P.L.116-94); FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Implementation of H.R.748, CARES Act (P.L.116-136); H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); S.2209/H.R.4128, Verifying Accurate Leading-edge IVCT Development Act 6 of 2021.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · second_quarter · Defense
H.R. 1319 - American Rescue Plan Act of 2021 H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022 H.R. 3584 - Invest in America Act Senate Department of Appropriations Act, 2021 Assistant Secretary of the Army (Acquisition, Logistics and Technology) Doug Bush concerning Army programs.
Client expense: $160,000 · Firm income: Not reported
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
2021 · first_quarter · Medical/Disease Research/Clinical Labs
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services); Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Coronavirus impact and response; Surprise billing; Implementation of H.R.3584/S.3049, Laboratory Access for Beneficiaries Act (P.L.116-94); FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Implementation of H.R.748, CARES Act (P.L.116-136); H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
| House |
| Referred to |
| May 28, 2021 |
| Oversight and Accountability Committee | House | Referred to | May 28, 2021 |
| Ways and Means Committee | House | Referred to | May 28, 2021 |
| Republican |
| NE |
| Elaine G. Luria | Democratic | VA |
| Elissa Slotkin | Democratic | MI |
| Jaime Herrera Beutler | Republican | WA |
| Jefferson Van Drew | Republican | NJ |
| Jenniffer González-Colón | Republican | PR |
| Jimmy Panetta | Democratic | CA |
| Josh Gottheimer | Democratic | NJ |
| Pete Stauber | Republican | MN |
| Peter Meijer | Republican | MI |
| Susie Lee | Democratic | NV |
| Thomas R. Suozzi | Democratic | NY |
| Tom Rice | Republican | SC |
| Van Taylor | Republican | TX |